Page last updated: 2024-11-06

mitomycin and Allergic Encephalomyelitis

mitomycin has been researched along with Allergic Encephalomyelitis in 5 studies

Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.

Research Excerpts

ExcerptRelevanceReference
"Our results found that Toxoplasma gondii infection in the brain increases SOCS3 expression and decreases the phosphorylation of STAT3, resulting in reducing IL-17A and IL-23, which suppress the differentiation and expansion of pathogenic Th17 cells, an important factor in MS development."1.62Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3. ( Ham, DW; Kim, SG; Lee, SH; Seo, SH; Shin, EH; Shin, JH, 2021)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's1 (20.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Ham, DW1
Kim, SG1
Seo, SH1
Shin, JH1
Lee, SH1
Shin, EH1
Kleist, C2
Mohr, E1
Gaikwad, S1
Dittmar, L1
Kuerten, S1
Platten, M1
Mier, W1
Schmitt, M1
Opelz, G2
Terness, P2
Oelert, T1
Ehser, S1
Chuang, JJ1
Lahdou, I1
Velten, F1
Hämmerling, GJ1
Arnold, B1
Mor, F1
Cohen, IR1
Mokhtarian, F1
Shirazian, T1
Batuman, O1
Shi, Y1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Single-arm Phase-I Trial for the Determination of Safety and Feasibility of the Intravenous Administration of Mitomycin C-treated Donor Peripheral Blood Mononuclear Cells (MICs) for Individualized Immunosuppression in Living Donor Kidney Transplant Reci[NCT02560220]Phase 114 participants (Actual)Interventional2015-08-05Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

5 other studies available for mitomycin and Allergic Encephalomyelitis

ArticleYear
Chronic Toxoplasma gondii Infection Alleviates Experimental Autoimmune Encephalomyelitis by the Immune Regulation Inducing Reduction in IL-17A/Th17 Via Upregulation of SOCS3.
    Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2021, Volume: 18, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Brain; Cisplatin; Enceph

2021
Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.
    Journal of translational medicine, 2016, 05-01, Volume: 14, Issue:1

    Topics: Animals; Apoptosis; Autoantigens; Cell Movement; Disease Models, Animal; Encephalomyelitis, Autoimmu

2016
Mitomycin C-treated dendritic cells inactivate autoreactive T cells: toward the development of a tolerogenic vaccine in autoimmune diseases.
    Proceedings of the National Academy of Sciences of the United States of America, 2008, Nov-25, Volume: 105, Issue:47

    Topics: Animals; Autoimmune Diseases; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; G1 Phase

2008
IL-2 rescues antigen-specific T cells from radiation or dexamethasone-induced apoptosis. Correlation with induction of Bcl-2.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Jan-15, Volume: 156, Issue:2

    Topics: Amino Acid Sequence; Animals; Antigens; Apoptosis; Base Sequence; Cells, Cultured; Cricetinae; Dexam

1996
The effects of oral myelin basic protein and dexamethasone treatment on experimental autoimmune encephalomyelitis.
    Annals of the New York Academy of Sciences, 1996, Feb-13, Volume: 778

    Topics: Administration, Oral; Animals; Antigens; Cells, Cultured; Combined Modality Therapy; Dexamethasone;

1996